FDA Leads Pharma Professional Services 
Clarivate
JANUARY 23, 2024
While some industry observers read this drop as a clear decline in productivity, others take a more optimistic view, attributing the decline to FDA submission calendar fluctuations and noting that 2022 numbers were not very different from the ten-year average. In fact, the number of NMEs has grown by 65% between 2013 and 2022.
Clarivate
FEBRUARY 22, 2024
53% of pharma CEOs report regulatory changes as a top disruptive trend* Gedeon Richter had a need to streamline regulatory monitoring and impact assessments. Our client is a major pharmaceutical company headquartered in Budapest, Hungary, with an expanding presence in Western Europe, Mainland China, Latin America and Australia.
Expert insights. Personalized for you.
52 
Let's personalize your content